Trials / Conditions / Influenza A H3N2
Influenza A H3N2
6 registered clinical trials studyying Influenza A H3N2.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain NCT06613737 | Hvivo | N/A |
| Completed | A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus NCT06385821 | NPO Petrovax | Phase 3 |
| Completed | Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus) NCT04204993 | Imperial College London | N/A |
| Completed | Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults NCT03743688 | Vanderbilt University Medical Center | — |
| Completed | Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With I NCT03315104 | Emergent BioSolutions | Phase 2 |
| Completed | Study Examining PrEP-001 in Healthy Subjects NCT03220048 | Hvivo | Phase 2 |